GlassScriptPhysician profile
Jared William Davis
NPI 1942664263
$8,291.10
in general payments reported to CMS, 2019-2025
28 companies · $3,287 in 2025
The $3,287 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.54 · 2022: $2,437 · 2023: $1,772 · 2024: $771 · 2025: $3,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,119 · Travel and Lodging: $2,710 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,118.95 |
| Travel and Lodging | $2,709.78 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,768.88 | 2023-2025 | Perclose Proglide, Esprit, Mitraclip |
| Boston Scientific Corporation | $1,958.10 | 2022-2025 | Watchman Access System |
| Edwards Lifesciences Corporation | $1,366.93 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $257.29 | 2022-2025 | Farxiga, Wainua |
| Medtronic, INC. | $234.00 | 2021-2025 | Ffrangio |
| Angiodynamics, INC. | $227.94 | 2022-2025 | Auryon Laser System 100-120 Vac |
| E.R. Squibb & Sons, L.L.C. | $221.60 | 2023-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $187.66 | 2023-2025 | |
| Abiomed | $170.56 | 2023-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.57 | 2024-2025 | Jardiance |
| Amgen INC. | $102.22 | 2022-2025 | Repatha, Repatha |
| Inari Medical, INC. | $93.20 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $85.98 | 2023-2025 | Verquvo |
| Pfizer INC. | $77.18 | 2023-2025 | |
| Cvrx, INC. | $68.57 | 2024 | Barostim Neo System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $52.57 | 2024-2025 | Indigo System |
| Bayer Healthcare Pharmaceuticals INC. | $44.78 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.78 | 2025 | Lifevest |
| Scpharmaceuticals INC. | $29.09 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $23.47 | 2024 | |
| Shockwave Medical, INC | $22.64 | 2025 | |
| Vital Connect, INC | $21.47 | 2025 | Vitalpatch Rtm |
| Novo Nordisk INC | $18.76 | 2025 | Wegovy |
| Philips North America LLC | $17.09 | 2024 | (Ao0) Igt Devices Intracardiac |
| Bridgebio Pharma, INC. | $15.76 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $14.82 | 2025 | Assure Wcd |
| Chiesi USA, INC. | $13.66 | 2025 | Kengreal, Cleviprex |
| Biotronik INC. | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.